CSPC Pharmaceutical GroupCSPCY +9.27%76 Days Payable is 128.97 as of Dec. 2025, which is 44% above its 10-year median of 89.59. GuruFocus rates CSPCY with a GF Score™ of 76/100 and a GF Value™ of $3.37 (Fairly Valued). The stock has 4 warning signs investors should review. Among 920 Drug Manufacturers companies, CSPC Pharmaceutical Group ranks better than 60% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CSPC Pharmaceutical Group Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Days Payable distribution charts can be found below:
* The bar in red indicates where CSPC Pharmaceutical Group's Days Payable falls into.
CSPC Pharmaceutical Group Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
CSPC Pharmaceutical Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSPC Pharmaceutical Group (CSPCY) has a Days Payable of 128.97 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CSPC Pharmaceutical Group and its competitors. This is 44% above median its historical median of 89.59. Over the past decade, CSPC Pharmaceutical Group's Days Payable has ranged from 71.22 to 141.06. According to the industry distribution chart, CSPC Pharmaceutical Group ranks #368 out of 920 companies in the Drug Manufacturers industry, placing it in the top 40%.
Is CSPC Pharmaceutical Group's Days Payable too high?
CSPC Pharmaceutical Group's current Days Payable of 128.97 is 44% above median its 10-year median of 89.59. Over the past 10 years, this metric has ranged from a low of 71.22 to a high of 141.06. The Drug Manufacturers industry median Days Payable is 90.84. CSPC Pharmaceutical Group's value of 128.97 is 42% above this industry median. Based on the distribution chart, CSPC Pharmaceutical Group ranks #368 out of 920 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, CSPC Pharmaceutical Group has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, CSPC Pharmaceutical Group ranks #368 out of 920 companies for Days Payable. This puts CSPC Pharmaceutical Group in the upper half of its industry. The industry median Days Payable is 90.84. CSPC Pharmaceutical Group's value of 128.97 is 42% above this benchmark. Historically, CSPC Pharmaceutical Group's own Days Payable has ranged from 71.22 to 141.06 over the past decade. While the company's 10-year median is 89.59 vs. the industry median of 90.84, CSPC Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CSPC Pharmaceutical Group's current Days Payable of 128.97 is 42% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CSPC Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CSPC Pharmaceutical Group's current Days Payable is 128.97, which is 44% above median its own 10-year median of 89.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group (CSPCY) is currently considered Fairly Valued. The stock's GF Value™ is $3.37, compared to a current price of $3.58 — trading 6.4% above its estimated fair value. The current Days Payable is 128.97, which is 44% above median its 10-year median of 89.59 and 42% above the Drug Manufacturers industry median of 90.84. CSPC Pharmaceutical Group's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For CSPC Pharmaceutical Group (CSPCY), the current Days Payable is 128.97 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CSPC Pharmaceutical Group (CSPCY) Overvalued in 2026?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued.
The current stock price of $3.58 is trading 6.4% above its estimated GF Value™ of $3.37.
GuruFocus considers CSPC Pharmaceutical Group to be Fairly Valued.
Key valuation signals for CSPCY:
Days Payable: 128.97 (44% above median its 10-year median of 89.59)
GF Value™: $3.37 vs. price of $3.58 (6.4% above fair value)
Industry Position: 42% above the Drug Manufacturers median (#368 of 920)
No single metric tells the full story. See the CSPCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
76GF Score
Get the complete analysis for CSPCY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSPCY has been successfully added to your 
